Fundraising FoxBiodol
Montpellier, FR · 1 known investors
Find your way into Biodol
Sign up to see every warm intro you have to Biodol
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biodol team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.
Investors · 1
V-Bio Ventureslisted by V-Bio VenturesGhent · $270K – $2.2M
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Biodol do?
- Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.
- Who are Biodol's investors?
- Biodol's investors include V-Bio Ventures.
- Where is Biodol headquartered?
- Biodol is headquartered in Montpellier, FR.